Christos Papadimitriou

Outpatient treatment of low-risk neutropenic fever in cancer patients using oral moxifloxacin.

Combination of ifosfamide, paclitaxel, and cisplatin for the treatment of metastatic and recurrent carcinoma of the uterine cervix: a phase II study of the Hellenic Cooperative Oncology Group.

High dose therapy with autologous stem cell transplantation for solitary bone plasmacytoma complicated by local relapse or isolated distant recurrence.

Treatment of Waldenstrom's macroglobulinemia with the combination of fludarabine and cyclophosphamide.

Second-line chemotherapy with gemcitabine and carboplatin in paclitaxel-pretreated, platinum-sensitive ovarian cancer patients. A Hellenic Cooperative Oncology Group Study.

Hormonal therapy with letrozole for relapsed epithelial ovarian cancer. Long-term results of a phase II study.

Treatment of ovarian germ cell tumors with a 3-day bleomycin, etoposide, and cisplatin regimen: a prospective multicenter study.

Clinicopathological features of ovarian carcinosarcomas: a single institution experience.

Serum lipid profile and hepatic steatosis of adult beta-thalassaemia patients with chronic HCV infection.

A phase II study of capecitabine plus oxaliplatin (XELOX): a new first-line option in metastatic colorectal cancer.

Extent of damage and repair in the p53 tumor-suppressor gene after treatment of myeloma patients with high-dose melphalan and autologous blood stem-cell transplantation is individualized and may predict clinical outcome.

Paclitaxel and carboplatin as first-line chemotherapy combined with gefitinib (IRESSA) in patients with advanced breast cancer: a phase I/II study conducted by the Hellenic Cooperative Oncology Group.

Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors.

Young age is associated with favorable characteristics but is not an independent prognostic factor in patients with epithelial ovarian cancer: a single institution experience.

The concurrence of microalbuminuria and retinopathy with cardiovascular risk factors; reliable predictors of asymptomatic coronary artery disease in type 2 diabetes.

Four cycles of paclitaxel and carboplatin as adjuvant treatment in early-stage ovarian cancer: a six-year experience of the Hellenic Cooperative Oncology Group.

Biweekly gemcitabine and cisplatin in platinum-resistant/refractory, paclitaxel-pretreated, ovarian and peritoneal carcinoma.

Laparoscopy in the evaluation of women with unexplained ascites: an invaluable diagnostic tool.

Adjuvant dose-dense sequential chemotherapy with epirubicin, CMF, and weekly docetaxel is feasible and safe in patients with operable breast cancer.

Advanced epithelial ovarian cancer in the elderly: chemotherapy tolerance and outcome.

Squamous cell esophageal carcinoma as a second primary malignancy in a woman with epithelial ovarian cancer.

Endovascular stenting for the management of port-a-cath associated superior vena cava syndrome.

Prevalence of anti-HAV antibodies in multitransfused patients with beta-thalassemia.

Paclitaxel, epirubicin, and carboplatin in advanced or recurrent endometrial carcinoma: a Hellenic Co-operative Oncology Group (HeCOG) study.

Adjuvant dose-dense sequential chemotherapy with epirubicin, CMF and weekly paclitaxel in patients with resected high-risk breast cancer: a Hellenic Cooperative Oncology Group (HeCOG) study.

Treatment with granulocyte colony stimulating factor is associated with improvement in endothelial function.

Bilateral metastases to extraocular muscles from lobular breast carcinoma.

Paclitaxel, topotecan, and carboplatin in metastatic endometrial cancinoma: a Hellenic Co-operative Oncology Group (HeCOG) study.

Carboplatin and paclitaxel versus cisplatin, paclitaxel and doxorubicin for first-line chemotherapy of advanced ovarian cancer: a Hellenic Cooperative Oncology Group (HeCOG) study.

Paclitaxel- and platinum-based postoperative chemotherapy for primary fallopian tube carcinoma: a single institution experience.

Assessment of somatic k-RAS mutations as a mechanism associated with resistance to EGFR-targeted agents: a systematic review and meta-analysis of studies in advanced non-small-cell lung cancer and metastatic colorectal cancer.

Granulosa cell tumor of the ovary: tumor review.

Actinomycosis of the appendix and pelvis: a case report.

Heat shock protein90 in lobular neoplasia of the breast.

Giant cell arteritis of the breast and breast cancer: paraneoplastic manifestation or concomitant disease? A case report.

A mixability theory for the role of sex in evolution.

Treatment of early uterine sarcomas: disentangling adjuvant modalities.

Temozolomide with radiation therapy in high grade brain gliomas: pharmaceuticals considerations and efficacy; a review article.

Embryonal rhabdomyosarcoma of the uterine cervix.

Excisional breast biopsy under local anesthesia: stress-related neuroendocrine, metabolic and immune reactions during the procedure.

Excision Repair Cross-Complementation Group 1 Enzyme as a Molecular Determinant of Responsiveness to Platinum-Based Chemotherapy for non Small-Cell Lung Cancer.

Weekly docetaxel with or without gemcitabine as second-line chemotherapy in paclitaxel-pretreated patients with metastatic breast cancer: a randomized phase II study conducted by the Hellenic Co-Operative Oncology Group.

Paraneoplastic humorally mediated hypercalcemia induced by parathyroid hormone-related protein in gynecologic malignancies: a systematic review.

Comparison of molecular markers expression in vacuum-assisted biopsies and surgical specimens of human breast carcinomas.

Breast self-examination and adherence to mammographic follow-up: an intriguing diptych after benign breast biopsy.

Histopathologic and genetic alterations as predictors of response to treatment and survival in lung cancer: a review of published data.

Effects of rosuvastatin on myeloperoxidase levels in patients with chronic heart failure: a randomized placebo-controlled study.

A randomized phase II study of carboplatin plus pegylated liposomal doxorubicin versus carboplatin plus paclitaxel in platinum sensitive ovarian cancer patients: a Hellenic Cooperative Oncology Group study.

Sex, mixability, and modularity.

Mucinous but not clear cell histology is associated with inferior survival in patients with advanced stage ovarian carcinoma treated with platinum-paclitaxel chemotherapy.

An impossibility theorem for price-adjustment mechanisms.

Endometrial cancer: what is new in adjuvant and molecularly targeted therapy?

Markers of bone remodeling and skeletal morbidity in patients with solid tumors metastatic to the skeleton receiving the biphosphonate zoledronic acid.

Hsp90 in the continuum of breast ductal carcinogenesis: Evaluation in precursors, preinvasive and ductal carcinoma lesions.

Immunohistochemical study of PTEN and phosphorylated mTOR proteins in familial and sporadic invasive breast carcinomas.

Interactions of Trivalent Lanthanide Cations with a New Hexadentate Di-Schiff Base: New Lanthanide(III) Complexes from (NE,N'E)-2,2'-(ethane-1,2-diylbis(oxy))bis(N-(pyridin-2-ylmethylene)ethanamine).

Decreased Hsp90 expression in infiltrative lobular carcinoma: an immunohistochemical study.

All about KRAS for clinical oncology practice: gene profile, clinical implications and laboratory recommendations for somatic mutational testing in colorectal cancer.

Developments in the systemic treatment of endometrial cancer.

Burkitt's lymphoma in pregnancy with bilateral breast involvement: case report with review of the literature.

Prophylactic antibiotics for the prevention of neutropenic fever in patients undergoing autologous stem-cell transplantation: results of a single institution, randomized phase 2 trial.

Venous thromboembolic events alert for gynecologic neoplasms.

Irinotecan/fluorouracil/leucovorin or the same regimen followed by oxaliplatin/fluorouracil/leucovorin in metastatic colorectal cancer.

Effects of rosuvastatin and allopurinol on circulating endothelial progenitor cells in patients with congestive heart failure: the impact of inflammatory process and oxidative stress.

IL4/STAT6 Signaling Activates Neural Stem Cell Proliferation and Neurogenesis upon Amyloid-β42 Aggregation in Adult Zebrafish Brain.

Serum MMPs and TIMPs: may be predictors of breast carcinogenesis?

An analytical contrast between fitness maximization and selection for mixability.

Gestational trophoblastic neoplasia with retroperitoneal metastases: a fatal complication.

Relapse of ovarian cancer with bone marrow infiltration and concurrent emergence of therapy-related acute myeloid leukemia: a case report.

Intermittent docetaxel chemotherapy in patients with castrate-resistant prostate cancer.

A randomized phase III trial of adjuvant chemotherapy with irinotecan, leucovorin and fluorouracil versus leucovorin and fluorouracil for stage II and III colon cancer: a Hellenic Cooperative Oncology Group study.

Sarcomas of the fallopian tube: disentangling a rare entity.

Systemic chemotherapy with pemetrexed and cisplatin for malignant peritoneal mesothelioma: a single institution experience.

Potential role of the alcohol and smoking in the squamous cell carcinoma of the head and neck: review of the current literature and new perspectives.

Outcomes after adjuvant chemotherapy in the treatment of high-risk urothelial carcinoma of the upper urinary tract (UUT-UC): results from a large multicenter collaborative study.

Molecularly targeted therapies in unresectable-metastatic gastric cancer: a systematic review.

Serum levels of HSP90 in the continuum of breast ductal and lobular lesions.

Paclitaxel and bevacizumab as first line combined treatment in patients with metastatic breast cancer: the Hellenic Cooperative Oncology Group experience with biological marker evaluation.

Endothelial vascular toxicity from chemotherapeutic agents: preclinical evidence and clinical implications.

Non-blood medical care in gynecologic oncology: a review and update of blood conservation management schemes.

Postoperative dose-dense sequential versus concomitant administration of epirubicin and paclitaxel in patients with node-positive breast cancer: 5-year results of the Hellenic Cooperative Oncology Group HE 10/00 phase III Trial.

Prognostic significance of phosphorylated STAT-1 expression in premenopausal and postmenopausal patients with invasive breast cancer.

Quiz case: a 19-year-old woman with hypercalcemia and abdominal pain.

Prevalence of BRCA1 mutations among 403 women with triple-negative breast cancer: implications for genetic screening selection criteria: a Hellenic Cooperative Oncology Group Study.

Developments in the systemic treatment of metastatic cervical cancer.

Exon 8 amplification of epidermal growth factor receptor (EGFR) in invasive breast carcinomas.

Serum CA 125, CA 15-3, CEA, and CA 19-9: a prognostic factor for uterine carcinosarcomas?

A woman with breast cancer and severe impaired lactose tolerance: an intriguing therapeutic dilemma.

HTERT MNS16A polymorphism in breast cancer: a case-control study.

HSP90, HSPA8, HIF-1 alpha and HSP70-2 polymorphisms in breast cancer: a case-control study.

Taxanes for breast cancer during pregnancy: a systematic review.

Cyclin D1 in invasive breast carcinoma: favourable prognostic significance in unselected patients and within subgroups with an aggressive phenotype.

Trastuzumab administration during pregnancy: a systematic review and meta-analysis.

Preserved Axin expression is associated with an aggressive phenotype in invasive breast carcinomas.

Prophylactic mastectomy: an appraisal.

Prevalence of BRCA1 mutations in familial and sporadic greek ovarian cancer cases.

Evaluation of the prognostic role of centromere 17 gain and HER2/topoisomerase II alpha gene status and protein expression in patients with breast cancer treated with anthracycline-containing adjuvant chemotherapy: pooled analysis of two Hellenic Cooperative Oncology Group (HeCOG) phase III trials.

An immunohistochemical evaluation of the proteins Wnt1 and glycogen synthase kinase (GSK)-3β in invasive breast carcinomas.

MMP-2 -1306C>T polymorphism in breast cancer: a case-control study in a South European population.

Novel approaches for concurrent irradiation in locally advanced cervical cancer: platinum combinations, non-platinum-containing regimens, and molecular targeted agents.

Molecularly targeted therapies in metastatic pancreatic cancer: a systematic review.

Breast cancer in women aged 25 years and younger.

Hsp90 inhibitors in breast cancer: a systematic review.

Ixabepilone administered weekly or every three weeks in HER2-negative metastatic breast cancer patients; a randomized non-comparative phase II trial.

Peripheral T-cell lymphoma: the role of hematopoietic stem cell transplantation.

Heat shock protein 90 (hsp90) expression and breast cancer.

A phase II, randomized, multicenter study evaluating the combination of lapatinib and vinorelbine in women with ErbB2 overexpressing metastatic breast cancer.

The key role of bisphosphonates in the supportive care of cancer patients.

Does pregnancy-associated breast cancer imply a worse prognosis? A matched case-case study.

Gynecologic oncology patients in the surgical high dependency unit: an analysis of indications.

Algorithms, games, and evolution.

alphaB-crystallin is a marker of aggressive breast cancer behavior but does not independently predict for patient outcome: a combined analysis of two randomized studies.

Dose-dense sequential adjuvant chemotherapy followed, as indicated, by trastuzumab for one year in patients with early breast cancer: first report at 5-year median follow-up of a Hellenic Cooperative Oncology Group randomized phase III trial.

Adjusting breast cancer patient prognosis with non-HER2-gene patterns on chromosome 17.

Plasmablastic lymphoma of the breast in an immunocompetent patient: long-lasting complete response induced by chemotherapy and autologous stem cell trasplantation.

Algorithms, complexity, and the sciences.

Adjuvant chemotherapy and acute toxicity in hypofractionated radiotherapy for early breast cancer.

Final overall survival analysis of a phase II trial evaluating vinorelbine and lapatinib in women with ErbB2 overexpressing metastatic breast cancer.

Regeneration, Plasticity, and Induced Molecular Programs in Adult Zebrafish Brain.

Safety and Tolerability of Anthracycline-Containing Adjuvant Chemotherapy in Elderly High-Risk Breast Cancer Patients.

Untreated newly diagnosed essential hypertension is associated with nonalcoholic fatty liver disease in a population of a hypertensive center.

Whole transcriptome data analysis of mouse embryonic hematopoietic stem and progenitor cells that lack Geminin expression.

Tumor Infiltrating Lymphocytes Affect the Outcome of Patients with Operable Triple-Negative Breast Cancer in Combination with Mutated Amino Acid Classes.

Evolution and Learning: Used Together, Fused Together. A Response to Watson and Szathmáry.

A Retrospective Analysis of Toxicity and Efficacy for 2 Hypofractionated Irradiation Schedules Versus a Conventional One for Post-Mastectomy Adjuvant Radiotherapy in Breast Cancer.

Prognostic Evaluation of Epidermal Growth Factor Receptor (EGFR) Genotype and Phenotype Parameters in Triple-negative Breast Cancers.

Prognostic Subcellular Notch2, Notch3 and Jagged1 Localization Patterns in Early Triple-negative Breast Cancer.

The Prognostic Value of the Immunohistochemical Expression of Phosphorylated RB and p16 Proteins in Association with Cyclin D1 and the p53 Pathway in a Large Cohort of Patients with Breast Cancer Treated with Taxane-based Adjuvant Chemotherapy.

Prognostic and predictive factors in patients with metastatic or recurrent cervical cancer treated with platinum-based chemotherapy.

Protein expression patterns of cell cycle regulators in operable breast cancer.

Correlation of MYC Gene and Protein Status With Breast Cancer Subtypes and Outcome of Patients Treated With Anthracycline-Based Adjuvant Chemotherapy. Pooled Analysis of 2 Hellenic Cooperative Group Phase III Trials.

Human TAU(P301L) overexpression results in TAU hyperphosphorylation without neurofibrillary tangles in adult zebrafish brain.